Yuri V. Kotelevtsev
Moscow, MOW 143025, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Irf5 Knockdown in Bone Marrow-Derived Macrophages Favors M1-to-M2 Transition.
Journal: Cells
Published: March 27, 2025
4-Methylumbelliferone, an Inhibitor of Hyaluronan Synthase, Prevents the Development of Oncological, Inflammatory, Degenerative, and Autoimmune Diseases.
Journal: Biochemistry. Biokhimiia
Published: March 09, 2025
Knockdown of Hyaluronan synthase 2 suppresses liver fibrosis in mice via induction of transcriptomic changes similar to 4MU treatment.
Journal: Scientific reports
Published: August 25, 2023
Cortisol Monitoring Devices toward Implementation for Clinically Relevant Biosensing In Vivo.
Journal: Molecules (Basel, Switzerland)
Published: February 11, 2023
4-Methylumbelliferone Targets Revealed by Public Data Analysis and Liver Transcriptome Sequencing.
Journal: International journal of molecular sciences
Published: October 06, 2022
Phenotypic Alteration of BMDM In Vitro Using Small Interfering RNA.
Journal: Cells
Published: July 14, 2022
Inhibition of hyaluronan secretion by novel coumarin compounds and chitin synthesis inhibitors.
Journal: Glycobiology
Published: February 08, 2021
Surface-specific washing-free immunosensor for time-resolved cortisol monitoring.
Journal: Talanta
Published: September 13, 2020
Finely tuned Prussian blue-based nanoparticles and their application in disease treatment.
Journal: Journal of materials chemistry. B
Published: July 11, 2020
In vitro assay for the efficacy assessment of AAV vectors expressing microdystrophin.
Journal: Experimental cell research
Published: November 28, 2019
4-methylumbelliferone Prevents Liver Fibrosis by Affecting Hyaluronan Deposition, FSTL1 Expression and Cell Localization.
Journal: International journal of molecular sciences
Published: November 27, 2019
Last Updated: 09/26/2026